Sicart Associates’s Adient ADNT Stock Holding History

Sicart Associates’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,225	Closed	-$306K	–	89
2016 Q4	$306K	Buy	+5,225	New	+$276K	0.21%	88

Other funds holding ADNT

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

KCM

Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Sicart Associates's ADNT Position: Q1 2017 in Review

Sicart Associates sold out of Adient (ADNT) in Q1 2017, closing a stake of 5,225 shares — an estimated $306K sold.

Sicart Associates first reported a position in ADNT in Q4 2016 and held it in 1 quarter. The position peaked at $306K in Q4 2016. 452 funds tracked by Wall St. Rank hold ADNT as of Q1 2017.

Sicart Associates reported no remaining Adient position as of Q1 2017 after selling out during the quarter.
Sicart Associates sold 5,225 Adient shares in Q1 2017, an estimated $306K.
Sicart Associates first reported a position in Adient in Q4 2016 and held it in 1 quarter.
Sicart Associates's Adient position peaked at $306K in Q4 2016.
452 funds tracked by Wall St. Rank held Adient as of Q1 2017.

Based on Sicart Associates's 13F filing for Q1 2017, filed 10 Apr 2017.